Papers: 10.1007/s10147-020-01824-5

https://doi.org/10.1007/s10147-020-01824-5

Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial

Cited by: 8
Author(s): Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, Hiroya Mizusawa, Hiroaki Nishimatsu, Karim Fizazi, Matthew R. Smith, Neal D. Shore, Teuvo L.J. Tammela, Ken Ichi Tabata, Nobuaki Matsubara, Masahiro Iinuma, Hirotsugu Uemura, Mototsugu Oya, Tetsuo Momma, Mutsushi Kawakita, Satoshi Fukasawa, Tadahiro Kobayashi, Iris Kuss, Marie Aude Le Berre, Amir Snapir, Toni Sarapohja, Kazuhiro Suzuki
Published: over 4 years ago

Software Mentions 1